Vanguard Group’s XBiotech XBIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.81M Sell
945,405
-117,367
-11% -$349K ﹤0.01% 3408
2025
Q1
$3.44M Sell
1,062,772
-1,832
-0.2% -$5.94K ﹤0.01% 3306
2024
Q4
$4.21M Buy
1,064,604
+2,625
+0.2% +$10.4K ﹤0.01% 3335
2024
Q3
$8.21M Buy
1,061,979
+25,010
+2% +$193K ﹤0.01% 3061
2024
Q2
$5.33M Buy
1,036,969
+141,654
+16% +$728K ﹤0.01% 3231
2024
Q1
$7.28M Buy
895,315
+13,804
+2% +$112K ﹤0.01% 3132
2023
Q4
$3.53M Buy
881,511
+9,068
+1% +$36.3K ﹤0.01% 3414
2023
Q3
$3.59M Hold
872,443
﹤0.01% 3384
2023
Q2
$5.18M Buy
872,443
+17,974
+2% +$107K ﹤0.01% 3280
2023
Q1
$2.95M Hold
854,469
﹤0.01% 3536
2022
Q4
$3M Buy
854,469
+352
+0% +$1.24K ﹤0.01% 3517
2022
Q3
$3.09M Sell
854,117
-176
-0% -$637 ﹤0.01% 3573
2022
Q2
$4.81M Sell
854,293
-74,384
-8% -$419K ﹤0.01% 3396
2022
Q1
$8.02M Sell
928,677
-12,130
-1% -$105K ﹤0.01% 3269
2021
Q4
$10.5M Buy
940,807
+55,825
+6% +$621K ﹤0.01% 3176
2021
Q3
$11.5M Buy
884,982
+33,566
+4% +$435K ﹤0.01% 3159
2021
Q2
$14.1M Buy
851,416
+107,826
+15% +$1.79M ﹤0.01% 3030
2021
Q1
$12.8M Buy
743,590
+11,411
+2% +$196K ﹤0.01% 3021
2020
Q4
$11.5M Sell
732,179
-5,717
-0.8% -$89.5K ﹤0.01% 2926
2020
Q3
$14.1M Sell
737,896
-154,651
-17% -$2.95M ﹤0.01% 2614
2020
Q2
$12.2M Buy
892,547
+173,378
+24% +$2.38M ﹤0.01% 2664
2020
Q1
$7.64M Sell
719,169
-270,133
-27% -$2.87M ﹤0.01% 2744
2019
Q4
$18.5M Sell
989,302
-101,182
-9% -$1.89M ﹤0.01% 2570
2019
Q3
$11.4M Buy
1,090,484
+108,064
+11% +$1.13M ﹤0.01% 2748
2019
Q2
$7.45M Buy
982,420
+259,660
+36% +$1.97M ﹤0.01% 3022
2019
Q1
$7.97M Buy
722,760
+285,154
+65% +$3.14M ﹤0.01% 2946
2018
Q4
$2.22M Sell
437,606
-396,917
-48% -$2.02M ﹤0.01% 3344
2018
Q3
$2.65M Buy
834,523
+43,648
+6% +$139K ﹤0.01% 3438
2018
Q2
$3.54M Sell
790,875
-29,045
-4% -$130K ﹤0.01% 3324
2018
Q1
$4.39M Buy
819,920
+9,185
+1% +$49.1K ﹤0.01% 3204
2017
Q4
$3.19M Sell
810,735
-239
-0% -$942 ﹤0.01% 3285
2017
Q3
$3.54M Buy
810,974
+25,340
+3% +$111K ﹤0.01% 3237
2017
Q2
$3.69M Buy
785,634
+41,458
+6% +$195K ﹤0.01% 3195
2017
Q1
$12.3M Buy
744,176
+33,899
+5% +$559K ﹤0.01% 2672
2016
Q4
$7.19M Buy
710,277
+22,394
+3% +$227K ﹤0.01% 2889
2016
Q3
$9.26M Buy
687,883
+185,265
+37% +$2.49M ﹤0.01% 2726
2016
Q2
$10.5M Buy
502,618
+105,511
+27% +$2.21M ﹤0.01% 2625
2016
Q1
$3.75M Buy
397,107
+32,495
+9% +$307K ﹤0.01% 3111
2015
Q4
$3.96M Buy
364,612
+112,976
+45% +$1.23M ﹤0.01% 3090
2015
Q3
$3.76M Buy
251,636
+48,883
+24% +$730K ﹤0.01% 3098
2015
Q2
$3.67M Buy
+202,753
New +$3.67M ﹤0.01% 3155